Morrisville-based Heat Biologics joins global effort to discover coronavirus vaccine
The Morrisville-based biotechnology company announced today that it has formally launched a program within its wholly-owned subsidiary, Zolovax, Inc., to develop a vaccine using its immune activating gp96 vaccine platform for treating or preventing infection from the SARS-CoV-2 coronavirus that causes COVID-19.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed